A phase 1 study evaluating the pharmacokinetic profile of a novel, proprietary, nano-formulated, lower-dose oral indomethacin

Garen Manvelian, Stephen Daniels, Roy Altman

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 1 study evaluating the pharmacokinetic profile of a novel, proprietary, nano-formulated, lower-dose oral indomethacin'. Together they form a unique fingerprint.

Medicine & Life Sciences